DNA & Synthetic Vaccines

Scientists take many approaches to designing vaccines against a microbe. These choices are typically based on fundamental information about the microbe, such as how it infects cells and how the immune system responds to it, as well as practical considerations, such as regions of the world where the vaccine would be used. A DNA vaccine against a microbe would evoke a strong antibody response to the free-floating antigen secreted by cells, and the vaccine also would stimulate a strong cellular response against the microbial antigens displayed on cell surfaces. The DNA vaccine couldn’t cause the disease because it wouldn’t contain the microbe, just copies of a few of its genes. In addition, DNA vaccines are relatively easy and inexpensive to design and produce. Inactivated vaccines can be composed of either whole viruses or bacteria, or fractions of either. Fractional vaccines are either protein-based or polysaccharide-based.

  • Mechanistic basis for DNA-raised immune responses
  • Plasmid Vector
  • Recombinant protein vaccines
  • Modulation of immune response
  • DNA vaccines delivery

Related Conference of DNA & Synthetic Vaccines

July 27-28, 2018

31st Annual Congress on Vaccines & Clinical Trials

Vancouver, Canada
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan

DNA & Synthetic Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in